Rein Therapeutics, Inc. - RNTX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 14
Latest filed: Sep 04, 2026
Form Count
8-K 4
SCHEDULE 13G 4
SCHEDULE 13G/A 4
4 2

Latest files

Filed Form Report period Accession SEC
Sep 04, 2026 8-K Sep 04, 2026 0001193125-26-383726 View
Aug 27, 2026 8-K Aug 21, 2026 0001193125-26-371260 View
Aug 14, 2026 SCHEDULE 13G 0001104659-26-097425 View
Aug 14, 2026 SCHEDULE 13G/A 0001104659-26-097114 View
Aug 13, 2026 SCHEDULE 13G/A 0000935836-26-000391 View
Jul 21, 2026 8-K Jul 20, 2026 0001193125-26-310315 View
Jul 14, 2026 SCHEDULE 13G/A 0002060757-26-000043 View
May 28, 2026 4 May 21, 2026 0001193125-26-245832 View
May 13, 2026 4 Apr 30, 2026 0001193125-26-220718 View
May 08, 2026 SCHEDULE 13G/A 0001697316-26-000012 View
May 08, 2026 SCHEDULE 13G 0001104659-26-057607 View
May 07, 2026 SCHEDULE 13G 0002073679-26-000049 View
May 06, 2026 SCHEDULE 13G 0000935836-26-000227 View
May 04, 2026 8-K Apr 30, 2026 0001193125-26-204006 View